The News: Celgene Corp. (Summit NJ) plummeted 20% Thursday (October 26, 2017) to $99.99 after releasing third-quarter earnings. And it wasn’t so much third-quarter revenue, which was up 10% year over year,… Read more »
The News: A former employee of Insys Therapeutics Inc. (Chandler AZ) pleaded guilty last week to having conspired to defraud insurers into paying for an expensive fentanyl-based drug that is… Read more »
The former CEO and president of Insys Therapeutics Inc. (Chandler AZ) was among six former company executives who were arrested last Thursday (December 8, 2016) on federal charges of leading… Read more »
Eli Lilly & Co. (Indianapolis RIN) said its experimental Alzheimer’s treatment failed to slow loss of cognitive ability in patients with mild symptoms, a major setback for the company and millions of… Read more »
The board of directors of Community Health Systems (Franklin TN) (CHS) has adopted a “poison pill” defense to make it harder for shareholders to accumulate a controlling interest in the… Read more »
Community Health Systems Inc. (Franklin TN), the troubled hospital operator, is exploring a possible sale of its business, Bloomberg News reported, citing “people with knowledge of the matter.” The company… Read more »
Federal regulators granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven medication. The approval… Read more »
Hillary Clinton’s personal health scare is a new market risk for jittery investors already spooked by central banks poised to disappear into the woodwork in the face of lax money policies. The 68-year-old Democratic… Read more »
Teva Pharmaceutical Industries Ltd. (Petach Tikva ISR) had a third patent on its top-selling multiple sclerosis drug, Copaxone, invalidated last Thursday by a U.S. agency, a further blow to its… Read more »
